Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Super League Reports Third Quarter 2025 Financial Results
-
Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual
-
Intermap Reports Third Quarter 2025 Results
-
Lysander Funds Limited Announces Disposition of Units of Canso Credit Income Fund
-
Martin Marietta Declares Quarterly Cash Dividend
-
Raleigh’s Lyle Plastic Surgery & Aesthetics Center Launches New GLP-1 Wellness Program for Sustainable Weight Loss
-
Raleigh’s Lyle Plastic Surgery & Aesthetics Center Launches New GLP-1 Wellness Program for Sustainable Weight Loss
-
Connecting critical mineral mines with clean electricity will power growth and competitiveness
-
Piedmont Realty Trust Announces Pricing of Senior Notes Offering
-
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
-
Caliber Reports Third Quarter 2025 Financial Results
-
Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
-
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
-
Astrotech Reports First Quarter of Fiscal Year 2026 Financial Results
-
Sienna Reports Third Quarter 2025 Financial Results and Continues Growth in Greater Toronto Area
-
United Community Banks, Inc. Announces Quarterly Cash Dividend On Common Stock
-
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
-
Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations
-
Innventure Reports Third Quarter 2025 Results
-
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
-
SAIC Announces Organizational Changes Intended to Simplify Structure, Sharpen Focus and Deliver Sustainable Long-Term Growth and Shareholder Value Creation
-
Inno Holdings Inc. Announces $50 Million “At-the-Market” Equity Offering Program
-
EZCORP Reports Fourth Quarter and Full Year Fiscal 2025 Results
-
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
-
Figure Technology Solutions Reports Third Quarter 2025 Results
-
Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
-
MediaAlpha Appoints Insurance Industry Veteran Ramon Jones to Board of Directors
-
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
-
Fennec Pharmaceuticals Announces Proposed Offering of Common Shares
-
BioSyent Schedules Q3 and YTD 2025 Earnings Release for November 20, 2025
-
Urbana Corporation Has Filed 2025 Third Quarter Interim Financial Statements
-
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update
-
First Watch Restaurant Group, Inc. to Participate at the Stephens Annual Investment Conference on November 18-19, 2025
-
PacBio to Present at Upcoming Investor Conferences
-
Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
-
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
-
BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
-
Birchtech Reports Third Quarter 2025 Financial Results
-
Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis
-
Hudson Technologies Appoints Kenneth Gaglione as Chairman of the Board, President and Chief Executive Officer
-
STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
-
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
-
SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
-
eGain to Participate in the Roth Technology Conference on November 19, 2025
-
Fluent Announces Third Quarter 2025 Financial Results; Commerce Media Solutions Annual Revenue Run Rate Exceeds $85 Million and Represents 40% of Consolidated Revenue
-
CapsoVision Reports Third Quarter 2025 Financial Results
-
Nasdaq Executives to Present at Upcoming Investor Conferences

